The Professor explains to Pete that some of the claims that he’s heard on TV about drug price controls are just spin. He shows Pete that whatever name you call them, drug price controls will reduce innovation and threaten people’s access to life-saving medicines....
PRI senior fellow in health care studies Dr. Henry Miller joins "Next Round with PRI" to give an update on what scientists are learning about COVID-19 and the progress in finding a vaccine. He also weighs in on whether schools should be reopening this fall, gives his thoughts on what the Trump administration is doing good and bad in fighting the pandemic, and offers advices on how we can reduce our chances of getting the coronavirus. https://youtu.be/r8PCYOt_h5Y...
The Professor and Pete go to the movies to learn why there is a drug affordability problem. After watching a scary thriller about list prices and net prices, an adventure on the prescription escalator, and a movie on biosimilars, they learn that a) specific patient populations are impacted by the drug affordability problem; and b) these issues can be fixed with targeted reforms to achieve innovation and affordability....
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is to bring drugs to market in the United States. Listen to the interview here. ...
The Professor and Pete learn how infusion drugs – drugs that you have to go to a doctor’s office, clinic or hospital to take – are sold and how the complex pricing environment encourages the use of higher cost drugs rather than lower cost alternatives like biosimilars....
As single-payer advocates such as Senator Bernie Sanders (I-VT) and House member Alexandria Ocasio-Cortez (D-NY) are seizing on the COVID-19 pandemic to push even more aggressively for a complete takeover of our health care system by the federal government, listen to a special presentation of our recent webinar featuring PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discussing why “Medicare for All” would be the wrong solution for the U.S. to embark on...
The Professor and Pete reach the most difficult part of their journey: understanding how medicines are sold. It’s a complex system that hurts patients and at times exposes them to paying excessive costs. They also learn that patients who get their prescriptions from a pharmacy don’t really benefit from drug discounts negotiated by pharmacy benefit managers (PBMs) – only PBMs and insurers do....
Sage the Detective Dog digs up clues on biologics and gene therapies – drugs that offer tremendous value for patients but are some of the most expensive drugs. Along the way, the Professor and Pete Paystoomuch learn that there are many distinct challenges to develop markets for competition and lower drug costs for each unique class of drug. ...
Listen to Dr. Henry Miller, PRI senior fellow in health studies, discuss the move by the WHO to pause hydroxychloroquine trials for Coronavirus treatment on the nationally-syndicated Lars Larson Show. TheLarsLarsonShow · Dr. Henry Miller - WHO pauses hydroxychloroquine trials for Coronavirus treatment...
Professor Salvare and Pete Paystoomuch watch government, the private sector, universities, and foundations pass the baton in a research relay race that is ultimately anchored by private companies that finish the race to develop new medicines that treat illnesses and create cures for devastating diseases....
Henry Miller talks about the unreliability of recent serology (blood) testing from the Netherlands, United Kingdom, and other European countries, and how they compare with the United States. Miller explains that more widespread testing with valid testing must be done to determine the COVID-19 impacts on populations. ...
Dr. Henry Miller joins the Lars Larson Show to discuss reopening in the United States, testimony from Dr. Anthony Fauci, concerns about coronavirus hotspots, and the low death rate in Japan allegedly attributed to masks. ...
Dr. Henry Miller talks about a recent Science Magazine article arguing about how the coronavirus, COVID-19, threatens major organs and vascular health of those infected unlike previous viruses and illnesses. ...
Professor Salvare and Pete Paystoomuch watch government, the private sector, universities, and foundations pass the baton in a research relay race that is ultimately anchored by private companies that finish the race to develop new medicines that treat illnesses and create cures for devastating diseases....
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes joins PRI's Next Round podcast to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” mandate for drug manufacturing. We also discuss a few positives changes that have occurred despite these tough times – the rise of telehealth and the rolling back...
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to debate shelter-in-place rollbacks by states and European countries and why it could be too early. Miller and Larson also debate the approaches of other countries and how their infection and death rate compare to the United States. Dr. Miller's segment begins at the 47:00 minute mark. Lars Larson National Podcast · Lars Larson National Podcast 04-21-20...
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. fights the coronavirus, policymakers must ensure that life-saving drugs are readily available to America’s patients,” said Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies and the...
Dr. Henry Miller joins the John Batchelor Show to provide an update on the state of testing in the United States and rest of the world. Dr. Miller explains that antibody testing will determine the true amount of cases, and also explains that only reliable, largely-used tests will help in the fight against the coronavirus. Dr. Miller also explains the danger of inaccurate and bad testing, like a recent example from the United Kingdom where their recent antibody tests were...
Sally C. Pipes joined the the Pat Miller Show in Cincinnati, Ohio to discuss the enormous benefits of the American private sector in the fight against the coronavirus epidemic. Pipes breaks down how the private sector industries in the United States are pushing innovations in the fight against the coronavirus epidemic including necessary equipment and medical innovation. Click here to listen to the entire interview. ...